 Intellect Design Arena Ltd consolidated Q2FY26 net profit up at Rs. 102.27 crores
Intellect Design Arena Ltd consolidated Q2FY26 net profit up at Rs. 102.27 crores Emkay Global Financial Services Ltd consolidated Q2 FY2026 PAT slumps to Rs. 45.95 lakhs
Emkay Global Financial Services Ltd consolidated Q2 FY2026 PAT slumps to Rs. 45.95 lakhs Dhanuka Agritech Ltd Q2 FY2026 PAT at Rs. 93.96 crores
Dhanuka Agritech Ltd Q2 FY2026 PAT at Rs. 93.96 crores Divyashakti Ltd Q2 FY26 loss at Rs. 8.34 lakhs
Divyashakti Ltd Q2 FY26 loss at Rs. 8.34 lakhs Mphasis Ltd Q2FY26 consolidated net profit up at Rs. 469.07 crores
Mphasis Ltd Q2FY26 consolidated net profit up at Rs. 469.07 crores 
              Mangalam Drugs & Organics Ltd has announced that the Board of Directors of the Company at its meeting held on October 30, 2006 had considered and approved the proposal of issue of 750000 Warrants convertible into Equity Shares with in 18 months from the date of allotment to Mr. Ramniwas R Dhoot (Promoter Group) and 650000 equity shares to M/s. Poonawala Investments & Industries Pvt Ltd (Public Category) on preferential allotment subject to the approval of the Shareholders pursuant to Section 81(1A) of the Companies Act, 1956 and subject to SEBI(DIP) Guidelines as amended from time to time.
Further the Company has informed that, Board has also decided to convene Extra Ordinary General Meeting of the Company on November 29, 2006, for considering the preferential allotment of Equity shares and warrants.